Ayurvedic Ingredient Deep Dive

Amla (Indian Gooseberry): The Complete Indian Industry Guide

Q: How do I ensure my amla powder retains vitamin C through shelf life?

Three factors matter most: (1) Drying method — salt pretreatment plus tray drying at 55°C retains 79.5–84.9% of ascorbic acid; freeze-drying outperforms oven-drying. (2) Storage conditions — real-world studies show amla powder ascorbic acid can fall to approximately 22% of its initial value over six months at summer temperatures. If you will carry a vitamin C claim on the label, you need accelerated and real-time stability data with end-of-shelf-life testing before you print it. (3) Packaging — oxygen-barrier packaging and cool storage are essential. For juice, glass with an oxygen-barrier cap outperforms PET for vitamin C retention across a 12–24 month shelf life.

Amla is India’s most commercially versatile Ayurvedic ingredient — yet almost every amla brand, blog and B2B listing in India quotes a 1963 vitamin C figure that India’s own national food composition authority has superseded. This guide corrects that, then gives you verified cultivation data, live trade prices across 10 product formats, the full regulatory landscape as of 2026, and the competitive reality of a category where Dabur holds 65.8% share in chyawanprash and Patanjali retails at ₹325/kg.

252 mg/100gVitamin C (ICMR-NIN 2017)

65.8%Dabur chyawanprash share

16.17% CAGRIndia Ayurvedic market

₹3.4–10LPrivate label launch cost

What Is Amla? Botanical Identity and Why It Matters for Manufacturers

Phyllanthus emblica L. (synonym: Emblica officinalis Gaertn.) is the scientifically accepted binomial for amla, also called Indian gooseberry or aonla. It belongs to the family Phyllanthaceae and is native to the Indian subcontinent, where it has been in continuous use as both food and medicine for over three millennia.

For a manufacturer or brand, the botanical identity question is not academic. Phyllanthus niruri (Bhumi amla) is morphologically distinct and far cheaper — but its polyphenol and ascorbate profile is different from P. emblica. With amla powder trading at ₹60–200/kg (IndiaMART, 4 Nov 2026) and Bhumi amla available at lower cost, botanical identity confirmation on every incoming lot is a commercial and legal necessity.

The Classical Name: Amalaki

In Ayurveda, amla is known as Amalaki (आमलकी) and is classified as a Rasayana — a substance that promotes longevity and rejuvenation. It is one of the three fruits in Triphala and the dominant ingredient in Chyawanprash. The Ayurveda Aahara Regulations 2022 (gazette-notified 5 May 2022) specifically recognise Amalaki across the 71 authoritative texts in Schedule A — a commercially useful regulatory fact for brands taking the food route.

Its Own HS Code

Amla is one of very few Indian botanicals with a dedicated export tariff line: HS code 14041061. This matters for export documentation and for distinguishing amla from general botanical product statistics.

The Vitamin C Fact Every Amla Brand Gets Wrong

Compliance caution: The 600 mg/100g claim is a 1963 figure. ICMR–National Institute of Nutrition’s Indian Food Composition Tables 2017 (IFCT 2017) measured amla total ascorbic acid at 252 ± 30.4 mg per 100g fresh fruit by RP-HPLC. The 600 mg figure is explicitly described as historical and superseded in that same document. Publishing 600 mg on a label or ad is a nutrient claim you cannot substantiate against India’s current official food data.

What IFCT 2017 Actually Shows (Food Code E021)

Source: ICMR–NIN Indian Food Composition Tables 2017, food code E021 ‘Gooseberry (Emblica officinalis)’, 5 regions sampled. Method: RP-HPLC (AOAC 985.33).
Nutrient (per 100g fresh, edible portion)	IFCT 2017 Value
Total ascorbic acid (vitamin C)	252 ± 30.4 mg
Total dietary fibre	7.75 ± 0.64 g
Citric acid	751 ± 8.5 mg
Moisture	87.02 ± 0.78 g
Energy	99 ± 19 kJ
Total folates	7.86 ± 1.27 µg

At 252 mg/100g, amla is still a nutritionally significant vitamin C source — roughly 4–5x a typical orange at ~50–60 mg/100g. It is not 20x, and it is not the world’s richest source. Acerola cherry and camu-camu both register higher. Making the accurate comparative claim is both defensible and differentiated, because almost no brand in India is doing it.

What Processing Does to Vitamin C

The processing story is commercially important. Research on drying shows that 1% salt pretreatment followed by tray drying at 55°C for 8 hours retains 79.5–84.9% of ascorbic acid (Sonkar et al., J Food Sci Technol 57:980–992, 2020). The recommended cultivar for powder is NA-7.

Storage is a bigger threat than drying. One study found amla powder ascorbic acid falling to approximately 22% of its initial value over six months when stored in conditions reaching 45°C — a realistic Indian summer scenario. If you intend to carry a vitamin C quantity claim on an amla powder label, you need end-of-shelf-life stability data before you print it.

Key Point: The classical Ayurvedic Svarasa Bhavana preparation measured 1.28% w/w ascorbic acid — roughly 3x higher than dried fruit at 0.37% (Scartezzini et al., J Ethnopharmacology 104:113–118, 2006). Classical processing methods may actually preserve bioactives better than modern drying.

Cultivation and Sourcing: Where India’s Amla Actually Comes From

State-Wise Production — Correcting the Standard Ranking

Most Indian content places Uttar Pradesh first in amla production. The Department of Agriculture & Farmers Welfare state data (via CEIC, 2024) shows a different picture:

MP is the largest amla-producing state, not UP as commonly stated. Rajasthan produces only ~1% of national output despite appearing in most ‘top amla states’ lists. Total national production: approximately 1.33 million tonnes.

Tamil Nadu stands out for yield efficiency at 23.7 t/ha — among the highest nationally — driven by intensive cultivation in Krishnagiri and Salem districts. For processors, Tamil Nadu amla offers a potential quality and yield argument; for a supply-chain diversification play, MP’s volume combined with Tamil Nadu’s yields creates optionality.

Raw Material Prices (Live, 4 November 2026)

Source: AgMarkNet via acrop.app, accessed 4 Nov 2026. The national median of ₹78.8/kg largely reflects retail-format farmers’ markets, not processor-grade wholesale.
Grade / Location	Price	Notes
Azadpur APMC mandi, Delhi	₹27.5/kg (₹2,750/quintal)	Best proxy for processor’s landed cost — wholesale, not retail
National mandi median	₹78.8/kg	Skewed by Tamil Nadu Uzhavar Sandhai retail markets
Processing grade (Dec–Feb season) [Industry Estimate]	₹15–35/kg	Bulk, ungraded, farm gate

Adulteration and Quality Risks

Active adulteration risks documented in literature include: substitution with Bhumi amla (Phyllanthus niruri); excessive moisture that inflates weight and accelerates microbial spoilage; and over-drying that eliminates the ascorbate before the product even reaches the buyer. For a B2B buyer, insist on NABL-accredited lab testing for botanical identity, ascorbic acid by HPLC, moisture, heavy metals, pesticide residues and microbiology on every incoming batch.

Ten Amla Product Formats: Trade Prices and Manufacturing Reality

Amla’s versatility is genuine: it converts to 10+ commercially active product categories. Here are the live B2B trade price ranges observed on IndiaMART on 4 November 2026, with estimated third-party manufacturing costs for a brand owner:

Trade prices: B2B asking prices on IndiaMART, 4 Nov 2026 — not audited transaction prices. Brand owner costs are industry estimates based on trade inputs; individual quotes will vary by volume, formulation and supplier.
Product Format	Trade Price Range	Est. Brand Owner Cost <em>[Industry Estimate]</em>
Amla juice, 1 L PET ambient	₹30/L–₹250/bottle	₹55–110/bottle
Amla juice, 500 ml	₹48–250/bottle	₹35–70/bottle
Amla powder, plain dried, bulk	₹60–200/kg	₹110–200/kg ex-works
Amla dry extract powder	₹440–650/kg	₹450–700/kg
Amla capsules, 60-count bottle	₹45–275/bottle trade	₹45–90/bottle
Amla candy	₹100–500/kg	₹130–250/kg
Amla murabba	₹80–280/kg	₹100–200/kg
Amla hair oil, 100 ml	₹20–100/bottle	₹25–60/bottle
Chyawanprash, 500g jar	₹140–650/jar trade	₹140–260/jar mainstream

The Chyawanprash Warning

Compliance caution: Patanjali retails 1 kg chyawanprash at ₹325 and 500g Special Chyawanprash at ₹215. These prices are at or below many third-party manufacturers’ asking cost for a 500g jar. A new brand entering on chyawanprash as its lead SKU faces a price-and-share wall that is structurally very difficult to overcome.

No-Added-Sugar and Jaggery: Validated Demand

The premiumisation signal in the chyawanprash category is real and already well-staked: Patanjali Chyawanprabha Advance No Added Sugar (₹440/750g), Baidyanath Chyawan Fit Sugarfree (₹270/500g), and IMC Chayawan Gold No Added Sugar (₹349/500g) all show that the no-sugar premium exists and is priced in. The same trend is visible in murabba, where sugar-free variants at ₹100–200/kg command a premium over standard listings.

Glass vs PET for Juice: The Honest Trade-Off

Industry estimate. Given that amla’s ascorbate degrades with oxygen exposure over time, a brand choosing glass with smaller packs and faster stock rotation can make a mechanistically substantiable quality argument — without an illegal claim.
Factor	PET	Glass
Packaging cost (1L)	~₹8–18/bottle	~₹22–45/bottle
Oxygen barrier	Poorer — faster ascorbate loss	Better — genuine vitamin C retention argument
Freight weight	Light, cheap	Heavy, breakage risk
Market positioning	Mainstream, commodity	Premium, export, cold-pressed

Regulatory Routes: FSSAI Food vs Ayurveda Aahara vs AYUSH Drug

An amla product can enter the Indian market through three distinct regulatory routes, each with different claims permissions, additive restrictions and licensing requirements. Choosing the wrong route is a launch-stopper.

Route determines: what claims you can make, what additives are permitted, which licence body you approach, and how the product is taxed. Many small brands take the FSSAI food route and fall into the Ayurveda Aahara zone inadvertently by using classical names and Ayurvedic framing.

Critical 2024–2026 Regulatory Developments

Sources: FSSAI directive (Business Standard, 3 June 2024); PIB AYUSH (5 May 2022); GST notification (busy.in, accessed 4 Nov 2026 — verify notification number on cbic.gov.in); FSSAI 2026 Amendment (Mondaq); Dabur v. Patanjali (SCC Online Del 4680, 3 July 2025).
Date	Development	Impact
3 June 2024	FSSAI bans ‘100% fruit juice’ on labels and ads	Affects every amla juice brand; ‘reconstituted’ mandatory
5 May 2022	FSS (Ayurveda Aahara) Regulations notified	New route for classical amla products
22 Sept 2025	GST on AYUSH medicaments (HSN 3003/3004) reduced to 5%	Real unit-economics improvement for AYUSH-licensed amla products
1 April 2026	FSSAI 2026 Amendment: perpetual licences, annual fee	Licence process simplification; easier for new brands
3 July 2025	Delhi HC: Patanjali restrained from disparaging chyawanprash ads	Court held Ayurvedic knowledge is NOT a prerequisite to making chyawanprash

Claims: What You Can and Cannot Say

The FSSAI (Advertising and Claims) Regulations 2018 and the Ayurveda Aahara Regulations together eliminate most standard amla marketing language:

Prohibited on the food route: ‘100% amla juice’, disease treatment or prevention claims (‘improves digestion’, ‘cures acidity’, ‘boosts immunity’ as a clinical claim)
Prohibited on the Ayurveda Aahara route: all of the above, plus added vitamins/minerals, any disease claim, non-approved additives
Legally safe framing: compositional statements (‘naturally contains vitamin C, 252 mg per 100g fresh fruit — ICMR-NIN 2017’), traditional-use statements (‘a classical Ayurvedic rasayana’), process claims (‘amber glass, smaller pack for better nutrient retention’)
Analytically risky: any vitamin C quantity claim on powder without end-of-shelf-life stability data proving retention through the declared shelf life

Key Point: The Delhi High Court’s July 2025 judgment in Dabur v. Patanjali explicitly held that making chyawanprash does not require prior knowledge of Ayurveda or the Vedas. A new entrant cannot be legally excluded on heritage grounds — but it can be excluded by ASCI’s substantiation requirement if its claims are not backed by evidence on file.

Market Landscape: What the Competitive Data Actually Shows

The Concentration Reality

Dabur Chyawanprash holds 65.8% market share as of FY2024-25 — its highest ever, up 140 basis points year-on-year, per Dabur’s own Management Discussion & Analysis. Dabur Amla Hair Oil holds the number one position in the Middle East. These are primary-source facts, not market research estimates.

Retail Price Benchmarks (Brand Stores, 4 November 2026)

Dabur figures from daburshop.com; Patanjali from patanjaliayurved.net; Baidyanath from IndiaMART. All accessed 4 November 2026.
Brand	Product	Price
Dabur	Chyawanprash (3X Immunity Action), 2 kg	MRP ₹895, selling ₹670
Dabur	Amla Juice, 1 L	MRP ₹520, selling ₹400
Dabur	Amla Hair Oil, 450 ml	MRP ₹300, selling ₹199
Patanjali	Chyawanprash, 1 kg	₹325
Patanjali	Special Chyawanprash, 1 kg	₹420
Patanjali	Jaggery Chyavanprash, 750 g	₹375
Patanjali	Chyawanprabha Advance No Added Sugar, 750 g	₹440
Baidyanath	Chyawan Fit Sugarfree, 500 g	₹270 (trade listing)

Where a New Brand Can Compete

Verified-Potency Positioning

At 252 mg/100g (ICMR-NIN 2017), publishing batch COAs with HPLC ascorbate is structurally unavailable to ₹30/litre competitors. This is a genuine, substantiable differentiator.

Amla Juice (Not Chyawanprash)

The juice segment is fragmented from ₹30–250/L trade, with Dabur at ₹400–520 retail for 1L. There is visible room between ₹30 commodity and ₹520 premium that chyawanprash does not offer.

Genuinely Certified Organic

‘Organic’ is used loosely across dozens of IndiaMART amla listings. NPOP certification, which the EU, Switzerland and USDA recognise as equivalent to their own organic standards (APEDA), is a verifiable export-path differentiator.

Third-Party Manufacturing (B2B)

Across approximately 110 amla trade listings captured, only three explicitly offered third-party manufacturing. This is the most commercially relevant gap for manufacturers: explicit, well-presented contract manufacturing for amla is under-marketed.

Clinical Evidence: What the Research Actually Supports

The Strongest Evidence: Metabolic and Lipid Outcomes

A 2023 meta-analysis of 5 randomised controlled trials (Setayesh et al., Diabetes & Metabolic Syndrome, PMID 36934568) found amla supplementation associated with significantly lower LDL cholesterol, total cholesterol and triglycerides (each p < 0.001), higher HDL cholesterol (p < 0.001), lower fasting blood glucose (p < 0.001) and reduced C-reactive protein (p = 0.002). Interventions ranged from 3 to 12 weeks. The authors concluded amla ‘shows promise’ and called for more research.

Compliance caution: These are association findings from 5 short-duration trials, not evidence of clinical benefit for a named disease. The authors themselves note the limitations. CRP reduction is an inflammatory marker — it is not evidence of improved immunity. Do not translate this finding into an immunity claim on a label or ad.

Claims Without Clinical Support

Source: RxList/Natural Medicines monograph on Indian gooseberry (accessed 4 Nov 2026). Most amla uses are rated ‘insufficient evidence’.
Popular Claim	Actual Evidence Status
‘Boosts immunity’	No human clinical trial found in this research pass. CRP reduction ≠ immunity evidence.
‘Stops hair fall / regrows hair’	No human RCT found. Available literature is in vitro and preclinical only.
‘Improves digestion’	Rated insufficient evidence in the Natural Medicines monograph.
‘Richest source of vitamin C’	Incorrect at 252 mg/100g. Acerola and camu-camu are higher. ‘Approximately 4–5x a typical orange’ is accurate.
‘Cures acidity’	Disease claim, prohibited under multiple regulations. Note that amla contains 751 mg/100g citric acid — it is itself acidic.
‘Detox / blood purifier’	No clinical evidence; not a recognised claim category under FSSAI.

Safety Cautions — Must Be Included in Manufacturer Documentation

Bleeding disorders: amla may increase bleeding or bruising
Surgery: stop at least 2 weeks before scheduled surgery due to bleeding risk
Diabetes medications: moderate interaction — amla may lower blood sugar further; monitor closely
Anticoagulants/antiplatelets (warfarin, aspirin, clopidogrel): moderate interaction — increased bruising/bleeding risk
Liver: some Ayurvedic formulations containing amla have been linked to liver damage; moderate interaction with hepatotoxic drugs
Pregnancy/breastfeeding: insufficient evidence — stick to food amounts
No established dose range from the clinical literature — follow the product label

Third-Party Manufacturing Economics: The Real Numbers

Why Third-Party Manufacturing Beats Own Unit for Most Amla Brands

An own Ayurvedic manufacturing unit requires at minimum 1,200 sq ft of industrial premises, two BAMS/BUMS degree-holders and two pharmacists on payroll, full GMP build-out under Schedule T, and an AYUSH licence taking approximately 60 days. Industry estimates put a compliant small unit at ₹40 lakh to ₹2 crore or more before the first bottle sells.

Third-party manufacturing eliminates the licence, the GMP capex and the qualified-person payroll. The manufacturer holds the licence and issues the Certificate of Analysis per batch. Total launch cost on the third-party route: approximately ₹3.4 lakh to ₹10.3 lakh for a 1–2 SKU test launch (see startup cost table below), excluding FSSAI and trademark fees which must be verified on FoSCoS and ipindia.gov.in respectively.

Startup Investment — Small Scale, 1–2 SKUs

All figures are industry estimates except where marked sourced. AYUSH licence government fee is sourced at ₹3,000 for the first 10 products (Rules 153 & 156, Drugs Rules 1945, via lawrbit.com). FSSAI and trademark fees must be verified on official portals.
Item	INR Range	Notes
Company / firm registration	₹2,000–15,000
FSSAI licence	Verify on FoSCoS	Now perpetual, annual fee from 1 April 2026
Trademark (1 class)	Verify on ipindia.gov.in + ₹5,000–15,000 attorney
Label and pack design (2 SKUs)	₹10,000–40,000
Packaging material, first print run	₹40,000–1,20,000	Usually the largest single first-run line item
First production run (e.g. 2,000 × 1L amla juice)	₹1,10,000–2,20,000	Cost anchored to trade price ranges above
Third-party lab testing + COA	₹15,000–40,000	Per SKU per batch; NABL-accredited lab
Website + payment gateway	₹20,000–80,000
Initial marketing (3 months)	₹50,000–2,00,000
Working capital buffer	₹50,000–1,50,000
Total (excluding unverified statutory fees)	≈ ₹3.4L–10.3L	Plus FSSAI and trademark fees — verify

Channel Margin Structures and What They Mean for MRP

These are industry estimates. The MLM multiple is the highest of any channel and explains why MLM amla products carry MRPs that look expensive next to Patanjali’s ₹325/kg chyawanprash — the payout structure requires it.
Channel	Typical Structure <em>[Industry Estimate]</em>
General trade	Distributor 8–12%, retailer 20–30% on MRP; brand needs ~3.5–5x cost-to-MRP
Modern trade / e-commerce	25–45% of MRP in fees, commissions, fulfilment, returns
D2C (own website)	No channel margin; customer acquisition cost often ₹400–1,200 for ₹400–600 order value
MLM / direct selling	Total payout to network 30–45% of business volume; MRPs typically set at 6–10x manufacturing cost

Chyawanprash Season: Book Early

Key Point: Chyawanprash is a winter-season product. Dabur’s FY2024-25 MDA explicitly attributes a category slowdown to a weaker winter. Contract manufacturing capacity for chyawanprash tightens sharply September–December. If you are planning a chyawanprash launch, book your manufacturer by August.

Start Your Amla Product Line with Expert Third-Party Manufacturing

MLM Products Manufacturer offers full third-party and private label manufacturing for amla juice, powder, capsules, chyawanprash and hair oil — with FSSAI and AYUSH-compliant production, batch COAs from NABL-accredited labs, and label compliance support. No minimum order on inquiry.

Request Amla Manufacturing Quote →

Amla Manufacturing & Market FAQs

What is the vitamin C content of amla?

India’s national food authority (ICMR–National Institute of Nutrition) measured amla total ascorbic acid at 252 ± 30.4 mg per 100g fresh fruit using RP-HPLC, as published in the Indian Food Composition Tables 2017. The commonly cited ‘600 mg’ figure comes from a 1963 measurement and is explicitly superseded by the 2017 data. At 252 mg/100g, amla is still a nutritionally significant vitamin C source (approximately 4–5x a typical orange), but brands should use the current verified figure to avoid regulatory risk on nutrient claims.

Which amla product format has the most commercial potential in 2026?

Amla juice in the ₹100–300 per litre range is the most accessible entry point — the segment is fragmented, with dozens of small suppliers at ₹30–65/L trade and Dabur at ₹400–520 retail, leaving visible room for a credibly positioned mid-market brand. Powder and capsules have lower entry costs but weaker differentiation. Chyawanprash is the hardest door — Patanjali retails at ₹325/kg and Dabur holds 65.8% category share. The most defensible positioning across all formats is verified potency with published batch COAs.

What regulatory route should an amla brand take — FSSAI food or AYUSH drug?

It depends on the product and the claims you want to make. The FSSAI food route is simpler and covers amla juice, powder, capsules and candy as standard food products — no disease claims, and the 2024 directive bans ‘100% juice’ labels. The Ayurveda Aahara route (FSS Regulations 2022) lets you use classical names and heritage framing, but adds restrictions: no added vitamins/minerals, no disease claims, only approved additives, and mandatory ‘ONLY FOR DIETARY USE’ labelling. The AYUSH drug licence (Form 24D/25D) is required for products intended as Ayurvedic medicaments — it comes with GMP under Schedule T and 5% GST from September 2025. Many brands inadvertently mix routes by using Ayurvedic language on FSSAI-registered products.

Can I claim amla ‘boosts immunity’?

Not safely. No human randomised controlled trial of amla for immunity was found in current literature. The 2023 meta-analysis (Setayesh et al., PMID 36934568) demonstrated lipid and glucose benefits across 5 short trials, not immune function. FSSAI’s Advertising and Claims Regulations 2018 require that all nutrient and health claims be substantiated, and ASCI Chapter I clause 5 specifically calls for extra care in ads aimed at people with ‘weakness, illness or infertility’. ASCI Chapter I clause 4 prohibits misleading by implication. The safest framing is compositional (‘naturally contains vitamin C’) and traditional-use (‘a classical Ayurvedic rasayana’).

What is the minimum order quantity for amla private label manufacturing?

MOQs vary enormously. IndiaMART shows two sourced data points: one supplier at 10 bottles minimum and one with no minimum order. These low-MOQ suppliers generally charge more per unit and may not offer custom formulations. For a credible mid-market launch, realistic MOQs are approximately 1,000–5,000 units for juice (1L PET), 5,000–10,000 capsules, and 500–2,000 jars of chyawanprash. Contact us for actual quotes on amla manufacturing — these figures are estimates, not binding offers.

How do I ensure my amla powder retains vitamin C through shelf life?

Three factors matter most: (1) Drying method — salt pretreatment plus tray drying at 55°C retains 79.5–84.9% of ascorbic acid; freeze-drying outperforms oven-drying. (2) Storage conditions — real-world studies show amla powder ascorbic acid can fall to approximately 22% of its initial value over six months at summer temperatures. If you will carry a vitamin C claim on the label, you need accelerated and real-time stability data with end-of-shelf-life testing before you print it. (3) Packaging — oxygen-barrier packaging and cool storage are essential. For juice, glass with an oxygen-barrier cap outperforms PET for vitamin C retention across a 12–24 month shelf life.

Is amla safe for all consumers?

Amla in food amounts is considered likely safe. However, the Natural Medicines monograph (RxList, accessed 4 Nov 2026) lists several cautions: potential increased bleeding risk (stop 2 weeks before surgery); moderate interactions with anticoagulants (warfarin, aspirin, clopidogrel) and diabetes medications; caution with hepatotoxic drugs; and insufficient evidence for pregnancy and breastfeeding (food amounts only). There is no clinically established dose range. These cautions should appear in your product’s safety documentation and are relevant to formulation decisions for specific audiences.

Sources & further reading

Amla (Indian Gooseberry) Complete Guide: Science, Cultivation, Products & Market 2026